researcher

Emory is recognized as one of the nation's leading research universities. In fiscal year 2012 Emory researchers received:

  • $518.6 million in total research funding awards
  • $481.7 million in health sciences research funding awards
  • $349 million in federal research funding awards, led by the National Institutes of Health with $299 million

In 2011, a study in the New England Journal of Medicine named Emory University as the nation's fourth largest contributor to the discovery of new drugs and vaccines by public-sector research institutions.

Emory is a leader in HIV research. More than nine in 10 HIV patients in the United States who are on lifesaving therapy take Emtriva (emtricitabine) or 3TC (lamivudine), both drugs created at Emory. One of the leading vaccine candidates against HIV was developed at the Emory Vaccine Center and the Yerkes National Primate Research Center.

The research partnership between Emory and Georgia Tech includes the No. 2-ranked Wallace H. Coter Department of Biomedical Engineering, the Georgia Tech-Emory Center for Regenerative Medicine, the Emory/Georgia Tech Predictive Health Institute and the nation's largest NIH-funded research program in nanomedicine.

Emory is one of eight NIH-sponsored Vaccine Evaluation and Trial Units conducting clinical trials for vaccines for infectious diseases, including H1N1 flu.

Emory is a leader in technology transfer, with 27 products in the marketplace and 12 more in human clinical trials. Since 1992, Emory has launched 51 start-up companies and has received a total of $788 million from the commercialization of its technologies.

Emory cardiologists helped develop lifesaving procedures including angioplasty and drug-eluting stents, and newer technologies such as off-pump surgery.

Neuroscience innovations by Emory faculty include the development of brain mapping to guide deep brain stimation for the treatment of Parkinson's and dystonia, and discovery of the gene responsible for fragile X syndrome, the most common cause of inherited mental retardation.

BIO Ventures for Global Health awarded the Global Health Primer, funded through an $800,000 grant from the Bill and Melinda Gates Foundation, to the Emory Institute for Drug Development in 2012. The award recognizes Emory's expertise in drug development, its rich academic environment and its strong commitment to global health.

Emory provides a top 15 work environment for life science postdoctoral research professionals in a 2012 ranking of national academic institutions, according to The Scientist.

Emory's School of Medicine ranked No. 16 nationally in National Institutes of Health grant funding to medical schools ($347.7 million), as of fall 2010.

The Emory Global Health Institute-China Tobacco Control Partnership is pursuing five new Programs of Excellence in Tobacco Control aimed at helping reduce the burden of tobacco use in China. Emory's Nell Hodgson Woodruff School of Nursing received $8.1 million from the Bill & Melinda Gates Foundation in 2010 for a project designed to improve maternal and newborn survival rates in rural Ethiopia.

Emory's SIRE and INSPIRE programs award research grants to undergraduates who would like to participate more fully in meaningful research early on in their academic careers.

Emory's campus boasts 1.7 million square feet of scientific research space.